[HTML][HTML] Emerging roles of miRNAs in the development of pancreatic cancer

M Fathi, S Ghafouri-Fard, A Abak, M Taheri - Biomedicine & …, 2021 - Elsevier
Pancreatic cancer is a fatal cancer which is expected to exceed breast cancer as the third
foremost source of cancer mortality by 2025. This cancer has been associated with several …

Pancreatic cancer in chronic pancreatitis: pathogenesis and diagnostic approach

G Le Cosquer, C Maulat, B Bournet, P Cordelier… - Cancers, 2023 - mdpi.com
Simple Summary Chronic alcoholic pancreatitis displays a cumulative risk of pancreatic
cancer estimated at 4% after 15 to 20 years, this risk being higher for hereditary pancreatitis …

Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning

M Kawai, A Fukuda, R Otomo, S Obata… - British Journal of …, 2024 - nature.com
Background Pancreatic cancer is often diagnosed at advanced stages, and early-stage
diagnosis of pancreatic cancer is difficult because of nonspecific symptoms and lack of …

miRNAs in pancreatic cancer progression and metastasis

ETY Mok, JL Chitty, TR Cox - Clinical & Experimental Metastasis, 2024 - Springer
Small non-coding RNA or microRNA (miRNA) are critical regulators of eukaryotic cells.
Dysregulation of miRNA expression and function has been linked to a variety of diseases …

Metastatic pancreatic cancer: Mechanisms and detection

X Chen, F Liu, Q Xue, X Weng… - Oncology Reports, 2021 - spandidos-publications.com
Pancreatic cancer (PC) is a lethal malignancy. Its prevalence rate remains low but continues
to grow each year. Among all stages of PC, metastatic PC is defined as late‑stage (stage IV) …

Advances in non-coding RNA sequencing

J Micheel, A Safrastyan, D Wollny - Non-coding RNA, 2021 - mdpi.com
Non-coding RNAs (ncRNAs) comprise a set of abundant and functionally diverse RNA
molecules. Since the discovery of the first ncRNA in the 1960s, ncRNAs have been shown to …

Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma—A Review of the Literature

J Wnuk, JK Strzelczyk, I Gisterek - International Journal of Molecular …, 2023 - mdpi.com
Pancreatic cancer (PC) is considered to be the seventh most common cause of cancer-
related deaths. The number of deaths caused by PC is estimated to increase in the future …

Diagnostic bioliquid markers for pancreatic cancer: What we have vs. what we need

GY Liou, CJ Byrd - Cancers, 2023 - mdpi.com
Simple Summary Among all types of pancreatic cancer, pancreatic ductal adenocarcinoma
(PDAC) is the most common type and has an extremely low survival rate. Early detection at …

Towards unravelling the role of ERα-targeting miRNAs in the exosome-mediated transferring of the hormone resistance

OE Andreeva, DV Sorokin, EI Mikhaevich, IV Bure… - Molecules, 2021 - mdpi.com
Hormone therapy is one of the most effective breast cancer treatments, however, its
application is limited by the progression of hormonal resistance, both primary or acquired …

[HTML][HTML] Diagnostic Utility of MicroRNAs in Pancreatic Cancers

W Jelski, J Mroczko, S Okrasinska, B Mroczko - Cancers, 2024 - mdpi.com
Pancreatic cancer (PC) is a serious malignant tumor with a high mortality rate, mainly due to
late diagnosis and a lack of effective therapeutic interventions. The possibility of recognizing …